《癌症研究及其治療的最新進展(英文版)》集全球癌症研究與治療領域的高水平專家集體之力，全面介紹了目前癌症領域的最新研究進展。內容包括：生物治療的研究和套用的詳細描述，超級干擾素的抗癌作用；抗體治療、免疫治療、腫瘤幹細胞研究，化學治療的研究和套用的介紹；細胞治療（特異性及非特異性）；中藥臨床和三氧化砷治療白血病；對全球發病率最高的肺癌、腸癌的研究，針對中國癌症發病率特別高的食道癌、鼻咽癌的研究等。《癌症研究及其治療的最新進展(英文版)》的讀者對象為所有從事癌症研究與治療的專家、研究生、大學生。
基本介紹
- 書名：癌症研究及其治療的最新進展
- 作者：劉新垣 (Xin-Yuan Liu) 帕斯卡 (Sidney Pestka)
- 出版社：清華大學出版社
- 頁數：674頁
- 開本：16
- 品牌：清華大學出版社
- 外文名：Recent Advances in Cancer Research and Therapy
- 類型：醫學
- 出版日期：2013年9月1日
- 語種：簡體中文, 英語
- ISBN：9787302326304
基本介紹,內容簡介,作者簡介,圖書目錄,
基本介紹
內容簡介
《癌症研究及其治療的最新進展(英文版)》由清華大學出版社出版。
作者簡介
作者：（美國）帕斯卡（Sidney Pestka）
圖書目錄
Preface
List of Contributors
1 Cancer Biotherapy： Progress in China
2 Cancer Targeting Gene—Viro—Therapy and Its Promising Future
3 Relationship Between Antiproliferative Activities and Class I MHC Surface Expression of Mouse Interferon Proteins on B16—Fl0 Melanoma Cells
4 Mitotic Regulator Hecl as a Potential Target for Cancer Therapy
5 Advances in Liposome—Based Targeted Gene Therapy of Cancer
6 Rewiring the Intracellular Signaling Network in Cancer
7 Research and Development of Highly Potent Antibody—Based Drug Conjugates and Fusion Proteins for Cancer Therapy
8 Cancer Stem Cell
9 p53： A Target and a Biomarker of Cancer Therapy？
10 Recombinant Adenoviral—p53 Agent （Gendicine）： Quality Control， Mecharusm of Action， and Its Use for Treatment of Malignant Tumors
11 Three—Dimensional Tumor Model and T—Lymphocytes Immunotherapy for Cancer
12 Advances in Cancer Chemotherapeutic Drug Research in China
13 Doxorubicin Cardiotoxicity Revisited： ROS Versus Top2
14 Biochemistry and Pharmacology of Human ABCC1/MRP1 and Its Role in Detoxification and in Multidrug Resistance of Cancer Chemotherapy
15 The Role of Traditional Chinese Medicine in Clinical Oncology
16 Effect of Arsenic Trioxide on Acute Promyelocytic Leukemia and Glioma： Experimental Studies， Clinical Applications， and Perspectives
17 Recent Advances in Nasopharyngeal Carcinoma Research and Its Pathogenesis
18 EsophageaI Carcinoma
19 Research on Colorectal Cancer in China
20 Molecular and Cellular Characteristics of Small CeH Lung Cancer： Implications for Molecular—Targeted Cancer Therapy
21 Possibility to Partly Win the War Against Cancer
About the Editors
List of Contributors
1 Cancer Biotherapy： Progress in China
2 Cancer Targeting Gene—Viro—Therapy and Its Promising Future
3 Relationship Between Antiproliferative Activities and Class I MHC Surface Expression of Mouse Interferon Proteins on B16—Fl0 Melanoma Cells
4 Mitotic Regulator Hecl as a Potential Target for Cancer Therapy
5 Advances in Liposome—Based Targeted Gene Therapy of Cancer
6 Rewiring the Intracellular Signaling Network in Cancer
7 Research and Development of Highly Potent Antibody—Based Drug Conjugates and Fusion Proteins for Cancer Therapy
8 Cancer Stem Cell
9 p53： A Target and a Biomarker of Cancer Therapy？
10 Recombinant Adenoviral—p53 Agent （Gendicine）： Quality Control， Mecharusm of Action， and Its Use for Treatment of Malignant Tumors
11 Three—Dimensional Tumor Model and T—Lymphocytes Immunotherapy for Cancer
12 Advances in Cancer Chemotherapeutic Drug Research in China
13 Doxorubicin Cardiotoxicity Revisited： ROS Versus Top2
14 Biochemistry and Pharmacology of Human ABCC1/MRP1 and Its Role in Detoxification and in Multidrug Resistance of Cancer Chemotherapy
15 The Role of Traditional Chinese Medicine in Clinical Oncology
16 Effect of Arsenic Trioxide on Acute Promyelocytic Leukemia and Glioma： Experimental Studies， Clinical Applications， and Perspectives
17 Recent Advances in Nasopharyngeal Carcinoma Research and Its Pathogenesis
18 EsophageaI Carcinoma
19 Research on Colorectal Cancer in China
20 Molecular and Cellular Characteristics of Small CeH Lung Cancer： Implications for Molecular—Targeted Cancer Therapy
21 Possibility to Partly Win the War Against Cancer
About the Editors
